Delcath Systems Inc DCTH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
4.77quote price arrow down-0.32 (-6.29%)
Volume
391,901
52 week range
2.25 - 7.99
Loading...
  • Open5.03
  • Day High5.05
  • Day Low4.75
  • Prev Close5.09
  • 52 Week High7.99
  • 52 Week High Date06/01/23
  • 52 Week Low2.25
  • 52 Week Low Date11/14/23

Key Stats

  • Market Cap109.341M
  • Shares Out22.92M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta0.54
  • YTD % Change14.66

KEY STATS

  • Open5.03
  • Day High5.05
  • Day Low4.75
  • Prev Close5.09
  • 52 Week High7.99
  • 52 Week High Date06/01/23
  • 52 Week Low2.25
  • 52 Week Low Date11/14/23
  • Market Cap109.341M
  • Shares Out22.92M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta0.54
  • YTD % Change14.66

RATIOS/PROFITABILITY

  • EPS (TTM)-2.97
  • P/E (TTM)-1.61
  • Fwd P/E (NTM)-3.00
  • EBITDA (TTM)-38.054M
  • ROE (TTM)-961.44%
  • Revenue (TTM)2.065M
  • Gross Margin (TTM)69.25%
  • Net Margin (TTM)-2,308.86%
  • Debt To Equity (MRQ)64.33%

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Delcath Systems Inc

 

Profile

MORE
Delcath Systems, Inc. is an interventional oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company’s proprietary products, HEPZATO Kit (melphalan hydrochloride for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan percutaneous hepatic perfusion (PHP) are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects during a...
John Sylvester
Independent Chairman of the Board
Gerard Michel
Chief Executive Officer, Director
Martha Rook Ph.D.
Chief Operating Officer
John Purpura
Executive Vice President - Global Head of Operations
Anthony Dias CPA
Vice President - Finance
Address
566 Queensbury Avenue
Queensbury, NY
12804
United States

Top Peers

SYMBOLLASTCHG%CHG
XAIR
Beyond Air Inc
1.74UNCHUNCH
NVNO
enVVeno Medical Corp
5.44+0.16+3.03%
BLGO
BioLargo Inc
0.3549+0.0155+4.5607%
MODD
Modular Medical Inc
1.85-0.10-5.13%
RBOT
Vicarious Surgical Inc
0.3015+0.0092+3.1475%